| Literature DB >> 23874949 |
Elena Gómez-Sanz1, Carmen Torres, Sara Ceballos, Carmen Lozano, Myriam Zarazaga.
Abstract
The objective of this study was to investigate the dynamics of nasal carriage by Staphylococcus aureus (SA) and Staphylococcus pseudintermedius (SP) among healthy dog-owning household members involved in 7 previous index cases of suspected anthropozoonotic (n = 4) and zoonotic (n = 3) interspecies transmission [4 direct cases, identical SA (n = 3) or SP (n = 1) in owner and dog; three indirect, SP in owner (n = 2) or SA in dog (n = 1)]. Co-carriage with methicillin-resistant coagulase-negative staphylococci (MRCoNS) was also evaluated. Sixteen owners and 10 dogs were sampled once every three months for one year. In total, 50 SA and 31 SP were analysed by MLST, and SA also by spa typing. All isolates were subjected to ApaI/SmaI-PFGE and antimicrobial resistance and virulence profiles were determined. All index owners were persistent SA carriers in all direct-anthropozoonotic transmission cases, while only one dog was persistent SA carrier. Owner and dog exhibited a persistent SP carriage status in the direct-zoonotic transmission case. SP was maintained in the index human over time in one indirect-zoonotic transmission case. Only one SP was methicillin-resistant. SA belonged to genetic backgrounds of MRSA pandemic clones: CC45, CC121, CC30, CC5 and CC398. Three individuals carried a MSSA t1451-ST398 clone with the erm(T)-cadD/cadX resistance genes. SA or SP were persistently detected in the nasal cavity of 7 (43.8%) and 2 (12.5%) owners, and in one and 2 dogs, respectively. SA was recovered as the single species in 10 owners and in one dog; SP in 3 owners and 4 dogs; and both bacterial species in one owner and 4 dogs. Co-carriage of SA or SP with MRCoNS isolates was common (30.7%). This is the first study on the dynamics of nasal carriage of SA and SP in healthy pet-owning household members. Dog-contact may play a role in the staphylococcal species distribution of in-contact individuals.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23874949 PMCID: PMC3706376 DOI: 10.1371/journal.pone.0069337
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Schematic representation of the dynamics of carriage of the seven households investigated.
MRCoNS, methicillin-resistant coagulase negative staphylococci. IT, bacterial species responsible for interspecies transmission. Type, type of interspecies transmission (Direct, Indirect). Case no, number of the households investigated in this study. Individuals are named H (for human) or D (dog) followed by the case number (1 to 7) and a lower-case letter to differentiate subjects per household; if necessary, a lower script number was added. Nomenclature of individuals involved in index cases (T0) is displayed with gray background. T0 to T4, the different samplings. Index clone, S. aureus or S. pseudintermedius clones responsible for interspecies transmission in index cases (T0).
Number of isolates detected and molecular characterization of SA and SP analyzed in this study.
| Clone | Isolation data | |||||||||||||
| Case | SA | SP | Individual | T0 | T1 | T2 | T3 | T4 | No isolates | Representative isolate | Resistance genes detected | Relevant virulence genes detected | ||
| 1 | MSSA-ST1654-A | H1a | + | + | + | + | + | 6 | C3494 |
| [ | |||
| D1a | + | |||||||||||||
| MSSA-ST2619-B | D1a | + | 1 | C4897 |
|
| ||||||||
| 2 | MSSA-ST121-C | H2a | + | + | + | + | + | 8 | C3931 |
|
| |||
| D2a | + | |||||||||||||
| H2b | + | |||||||||||||
| H2c | + | |||||||||||||
| MRSP-ST71-I | D2a | + | 1 | C3930 |
|
| ||||||||
| MSSA-ST5-D | H2d | + | + | 3 | C3935 |
|
| |||||||
| H2e | + | |||||||||||||
| MSSP-ST77-II | D2a | + | + | + | 4 | C5102 |
|
| ||||||
| H2c | + | |||||||||||||
| MSSA-ST398-E | H2c | + | + | 4 | C5587 |
|
| |||||||
| H2d | + | + | ||||||||||||
| 3 | MSSA-ST45-F | H3a1 | + | + | + | + | + | 15 | C2919 |
| [ | |||
| H3a2 | + | + | + | + | + | |||||||||
| D3a | + | + | + | + | + | |||||||||
| MSSP-ST6-III | D3a | + | 1 | C3953 |
|
| ||||||||
| 4 | MSSA-ST121-G | D4a | + | 1 | C2727 | - |
| |||||||
| MSSP-ST42-IV | D4a | + | + | + | 3 | C5552 |
|
| ||||||
| 5 | MSSP-ST142-V | H5a | + | 3 | C2915 |
|
| |||||||
| D5a | + | + | ||||||||||||
| MSSP-ST185-VI | H5a | + | + | + | 6 | C5578 |
|
| ||||||
| D5a | + | + | + | |||||||||||
| 6 | MSSP-ST100-VII | H6a | + | 3 | C3469 |
|
| |||||||
| D6b | + | + | ||||||||||||
| MSSP-ST70-VIII | H6a | + | + | + | + | 9 | C5562 |
|
| |||||
| D6b | + | |||||||||||||
| D6c | + | + | ||||||||||||
| D6d | + | |||||||||||||
| D6e | + | |||||||||||||
| MSSA-ST30-H | H6b | + | + | + | + | 4 | C5559 |
| ( | |||||
| MSSA-ST398-E | D6b | + | 1 | C5086 |
|
| ||||||||
| 7 | MSSP-ST21-IX | H7a | + | 1 | C3917 |
|
| |||||||
| MSSA-ST30-I | H7b | + | + | + | + | + | 5 | C3916 |
|
| ||||
| MSSA-ST5-J | H7c | + | + | 2 | C3918 |
|
| |||||||
| Total | 23 | 17 | 17 | 16 | 17 | 14 | 81 | |||||||
MSSA, methicillin-susceptible S. aureus; MSSP, methicillin-susceptible S. pseudintermedius.
Clones were designated as follows: bacterial species (MSSA or MSSP)-MLST-PFGE profile.
Genes physically linked are displayed in square brackets and those possibly linked based on bibliography are shown in brackets.
Inducible clindamycin resistance.
Different spa types present among the S. aureus clones per household during the sample period (T0–T4), positive individuals and correspondent clones.
| Case |
| repeats | Clone | Sampling | Individual/s |
| 1 | t021 | 15-12-16-02-16-02-25-17-24 | MSSA-ST1654-A | T0, T1, T2, T3, T4 | H1a, D1aT0 |
| t159 | 14-44-13-12-17-17-23-18-17 | MSSA-ST2619-B | T3 | D1a | |
| 2 | t159 | 14-44-13-12-17-17-23-18-17 | MSSA-ST121-C | T0, T1, T2, T3, T4 | H2a, H2bT1, H2cT1, D2aT0 |
| t002 | 26-23-17-34-17-20-17-12-17-16 | MSSA-ST5-D | T0, T1 | H2d, H2eT0 | |
| t1451 | 08-16-02-25-34-25 | MSSA-ST398-E | T3, T4 | H2b, H2d | |
| 3 | t073 |
| MSSA-ST45-F | T0, T1, T2, T3, T4 | H3a1 T0, T3, T4, H3a2, D3a |
| t116 |
| MSSA-ST45-F | T1 | H3a1 | |
| t026 |
| MSSA-ST45-F | T2 | H3a1 | |
| 4 | t151 | 26-17-20-17-16 | MSSA-ST121-G | T0 | D4a |
| 6 | t1071 | 26-23-12-23-02-34-34 | MSSA-ST30-H | T1, T2, T3, T4 | H6b |
| t1451 | 08-16-02-25-34-25 | MSSA-ST398-E | T3 | D6b | |
| 7 | t012 | 15-12-16-02-16-02-25-17-24-24 | MSSA-ST30-I | T0, T1, T2, T3, T4 | H7b |
| t002 | 26-23-17-34-17-20-17-12-17-16 | MSSA-ST5-J | T0, T1, T2 | H7C |
When an individual was not positive for the specific spa type in all indicated samplings the positive sampling is indicated in superscript. Boldface and dashes added to facilitate comparison of spa repeats in the different isolates of clone MSSA-ST45-F.
Figure 2Distribution of investigated individuals (owners, dogs) related to the SA and/or SP carriage as a summary of the sampling year (T0–T4).
Figure 3Number of investigated individuals (owners and dogs) with different S. aureus (SA) and S. pseudintermedius (SP) carriage status over the sample year (T0–T4).
It should be noted that the sum is higher than the total number of isolates given that individuals could belong to 2 distinct carriage types depending on bacterial species.
Characteristics of the MRCoNS recovered in the SA/SP positive individuals per household.
| Antimicrobial resistance profile | Concomitant SA/SP clone | |||||||
| Case | Clone | Individual | Sampling | Isolate | Phenotype of resistance | Resistance genes detected | SA | SP |
| 1 | MRSE-1 | D1a | T3 | C4812 | P-O-F-E |
| MSSA-ST2619-B | |
| 2 | MRSE-2 | H2a | T2 | C4807 | P-O-F-E-M |
| MSSA-ST121-C | |
| MRSE-3 | H2d | T4 | C5588 | P-O-F |
| MSSA-ST398-E | ||
| 3 | MRSE-4a | H3a1 | T1 | C3956 | P-O-F |
| MSSA-ST45-F | |
| MRSE-4b | H3a1 | T3 | C5097 | P-O-F-M |
| MSSA-ST45-F | ||
| MRSE-4b | H3a2 | T2 | C4798 | P-O-F-M |
| MSSA-ST45-F | ||
| MRSE-5 | H3a2 | T1 | C3958 | P-O-F-T-E-To |
| MSSA-ST45-F | ||
| MRSE-5 | H3a1 | T2 | C4796 | P-O-F-T-E-To |
| MSSA-ST45-F | ||
| MRSE-5 | H3a1 | T4 | C5573 | P-O-F-T-E-To |
| MSSA-ST45-F | ||
| 5 | MRSH-6 | D5a | T1 | C3960 | P-O-F-E-X-Fu |
| MSSP-ST142-V | |
| MRSE-7 | D5a | T4 | C5577 | P-O-F |
| MSSP-ST185-VI | ||
| 6 | MRSE-8 | H6a | T1 | C3945 | P-O-F-G-K-M-Fu |
| MSSP-ST70-VIIIa | |
| MRSE-8 | H6a | T2 | C4791 | P-O-F-G-K-M-Fu |
| MSSP-ST70-VIIIb | ||
| MRSE-8 | H6a | T3 | C5093 | P-O-F-G-K-M-Fu |
| MSSP-ST70-VIIIb | ||
| MRSE-8 | H6a | T4 | C5564 | P-O-F-G-K-Fu |
| MSSP-ST70-VIIIc | ||
| MRSE-8 | H6b | T4 | C5558 | P-O-F-G-K-M-Fu |
| MSSP-ST70-VIIIc | ||
| MRSE-9 | H6b | T2 | C4789 | P-O-F-G-To-K |
| MSSA-ST30-H | ||
| MRSE-9 | D6c | T2 | C4787 | P-O-F-T |
| MSSP-ST70-VIIIb | ||
| 7 | MRSE-10 | H7b | T4 | C5581 | P-O-F-E |
| MSSA-ST30-J | |
MRSE, methicillin-resistant S. epidermidis; MRSH, methicillin-resistant S. haemolyticus.
P, penicillin; O, oxacillin; F, cefoxitin; E, erythromycin; M, mupirocin; Cp, ciprofloxacin; To, tobramycin; X, co-trimoxazol; Fu, fusidic acid; G, gentamicin; K, kanamycin; T, tetracycline.
Fusidic acid resistance genes fusB and fusC were not detected.
isolate C5564 was mupirocin susceptible regardless the presence of the mupA gene.